Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancer.
Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancer.
复制标题
DOI:
10.1155/2012/439235
复制
发表时间:
2012
影响因子:
--
通讯作者:
Hengchen Z
中科院分区:
文献类型:
--
作者:
Youlin K;Li Z;Xiaodong W;Xiuheng L;Hengchen Z
Immune regulation has been shown to be involved in the progressive growth of some murine tumours. Interruption of immune regulatory pathways via activation of 4-1BB or cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blockade appears to be a promising strategy for cancer immunotherapy. In this study, we examined the effectiveness of 4-1BBL-expressing tumor cell vaccine in combination with CTLA-4 blockade on rejection of murine prostate cancer RM-1. We found that the combination of both a vaccine consisting of 4-1BBL-expressing RM-1 cells and CTLA-4 blockade resulted in regression of RM-1 tumors and a significant increase in survival of the tumour cell recipients, compared to that of either treatment alone. The combined vaccination resulted in higher CTL against RM-1 cells and increased secretion of IFN-γ, TNF-α, and IL-2 in the mix-cultured supernatant. These results suggest that combining activation of 4-1BB and blockade of CTLA-4 may offer a new strategy for prostate cancer immunotherapy.
登录
查看更多内容
影响因子:
3.7
作者:
Curran MA;Kim M;Montalvo W;Al-Shamkhani A;Allison JP
通讯作者:
Allison JP
影响因子:
24.1
作者:
Li, Qiaoxia;Ai, Jun;Shan, Baoen
通讯作者:
Shan, Baoen
影响因子:
--
作者:
Aldrich JF;Lowe DB;Shearer MH;Winn RE;Jumper CA;Kennedy RC
通讯作者:
Kennedy RC
影响因子:
9.7
作者:
Met, Ö;Wang, MJ;Claesson, MH
通讯作者:
Claesson, MH
影响因子:
4.3
作者:
Habib-Agahi, Mojtaba;Jaberipour, Mansooreh;Searle, Peter F.
通讯作者:
Searle, Peter F.